Stay updated on Nivolumab in IDH-Mutant Gliomas Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in IDH-Mutant Gliomas Clinical Trial page.

Latest updates to the Nivolumab in IDH-Mutant Gliomas Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2, indicating a minor site maintenance or version update; there are no changes to study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check18 days agoChange DetectedThe page now displays Revision: v3.4.1, replacing Revision: v3.4.0.SummaryDifference0.1%

- Check19 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1.SummaryDifference0.1%

- Check27 days agoChange DetectedUI and metadata updates were made: a glossary toggle is now displayed, and the 'Last Update Submitted that Met QC Criteria' label capitalization was adjusted. The page now shows a 'No FEAR Act Data' note and the revision is updated to v3.4.0 (from v3.3.4).SummaryDifference0.2%

- Check34 days agoChange DetectedAdded the Results First Posted and Last Update Posted fields, and removed the Results First Posted (Estimated) and Last Update Posted (Estimated) fields. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4. No substantive changes to the study details or page behavior are evident.SummaryDifference0.1%

Stay in the know with updates to Nivolumab in IDH-Mutant Gliomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in IDH-Mutant Gliomas Clinical Trial page.